The Role of Bilastine in Treating Paediatric Patients with Allergic Rhinoconjunctivitis and Urticaria (JM test)

Bilastine is a second-generation antihistamine that has proven efficacy in treating urticaria and both seasonal and perennial allergic rhinitis.^1,2 It has been shown to have a rapid onset of action with fast effect as early as 30 minutes, and prolonged duration of effect of more than 24 hours in adults.^2–4 In paediatric patients, the therapeutic dose was identified based on the results of a pharmacokinetic study demonstrating that bilastine 10 mg once daily in children aged 2 to 11 years offers the same systemic exposure as 20 mg once daily in adults.